What Raises and Lowers ApoB and hsCRP Levels

What You'll Discover

‍

What ApoB and hsCRP actually measure
What drives each marker up and down
Where melatonin fits in
Normal ranges and when to retest

‍

A Quick Baseline on Each Marker

‍

ApoB (Apolipoprotein B) is the protein that coats every atherogenic lipoprotein particle, including LDL, VLDL, and IDL. Because each particle carries exactly one ApoB molecule, measuring ApoB gives you a direct particle count. A high ApoB means more particles are circulating and available to infiltrate artery walls. Standard LDL misses this, particularly in people with metabolic syndrome or high triglycerides, where particle count and cholesterol mass often diverge.

‍

Optimal ApoB: below 80 mg/dL. Above 100 mg/dL is considered elevated.

‍

hsCRP (high-sensitivity C-reactive protein) is produced by the liver in response to inflammatory signals. Chronically elevated hsCRP reflects ongoing low-grade inflammation in blood vessel walls, even when you have no symptoms. It adds cardiovascular risk information beyond what lipids alone provide.

‍

Optimal hsCRP: below 1.0 mg/L. Between 1.0 and 3.0 is average risk. Above 3.0 mg/L indicates elevated cardiovascular risk.

‍

You can read a deeper breakdown of ApoB ranges and what your result means if you want more on interpretation.

What Raises ApoB

Factor	Mechanism
Insulin resistance / metabolic syndrome	Liver overproduces VLDL, flooding circulation with atherogenic particles
High refined carbohydrate intake	Drives triglyceride production, increases VLDL output
High saturated fat intake	Downregulates LDL receptors, reducing particle clearance
Hypothyroidism	Slows LDL receptor activity, raises particle residence time
Chronic kidney disease	Impairs lipoprotein clearance
Genetic hypercholesterolaemia	Inherited receptor dysfunction; unresponsive to lifestyle alone
Excess body fat (particularly visceral)	Amplifies hepatic VLDL production
Smoking	Oxidises LDL particles, making them more atherogenic

The strongest driver most people can influence is insulin resistance. When cells stop responding to insulin efficiently, the liver compensates by producing more VLDL. Each VLDL particle carries one ApoB. This is why metabolic health and cardiovascular health are closely linked.

What Lowers ApoB

Factor	Effect
Statins	Strong ApoB reduction via LDL receptor upregulation
Reducing refined carbohydrates	Lowers VLDL output from the liver
Losing visceral fat	Reduces hepatic VLDL overproduction
Increasing aerobic exercise	Improves insulin sensitivity, reduces particle burden
Increasing dietary fiber	Binds bile acids, reduces cholesterol recycling
PCSK9 inhibitors	Powerful pharmacological option for high-risk patients
Improving thyroid function	Restores normal LDL receptor activity

Each 10 mg/dL drop in ApoB is associated with roughly a 9% reduction in cardiovascular event risk. Small, sustained improvements matter.

What Raises hsCRP

Factor	Mechanism
Excess visceral adipose tissue	Fat tissue secretes pro-inflammatory cytokines continuously
Poor sleep quality or short sleep duration	Activates sympathetic nervous system, raises IL-6 and TNF-α
Insulin resistance	Creates a chronic low-grade inflammatory state
Smoking	Direct endothelial damage, sustained inflammatory signaling
Ultra-processed food diet	High in trans fats and refined carbs, promotes oxidative stress
Periodontal disease	Chronic oral infection drives systemic CRP elevation
Psychological stress	Cortisol dysregulation amplifies inflammatory pathways
Sedentary behavior	Reduces anti-inflammatory effects of regular muscle contraction
Alcohol (heavy or chronic use)	Damages gut barrier, increases endotoxin translocation, raises inflammation

Sleep is particularly underappreciated here. Even a few nights of poor sleep can raise hsCRP measurably. Chronically disrupted sleep keeps inflammatory markers persistently elevated. Magnesium, sleep, and cortisol all connect for lowering inflammation.

What Lowers hsCRP

Factor	Effect
Regular aerobic exercise	One of the most reliable hsCRP reducers
Weight loss (especially visceral fat)	Removes primary source of inflammatory cytokines
Mediterranean-style diet	Anti-inflammatory fatty acids, polyphenols, fiber
Quitting smoking	Removes sustained endothelial damage signal
Treating sleep apnea	Reduces nocturnal hypoxia-driven inflammation
Statins	Anti-inflammatory effect independent of LDL lowering
Omega-3 fatty acids	Reduce IL-6 and TNF-α production
Reducing alcohol intake	Restores gut barrier integrity, lowers endotoxin load

‍

Addressing visceral fat tends to move both ApoB and hsCRP simultaneously, which is why weight loss often produces outsized improvements in cardiovascular risk beyond what either marker alone would suggest.

‍

How Often to Retest

Scenario	Suggested Interval
Baseline, no known risk factors	Every 12 months
Elevated ApoB or hsCRP, making lifestyle changes	Every 3–6 months
On statin or lipid-lowering medication	Every 3 months until stable
Post-significant weight loss or diet change	8–12 weeks after change

Both markers respond to sustained changes rather than short interventions. A single week of clean eating will not meaningfully shift ApoB. Three to six months of consistent dietary and exercise changes are required for measurable improvements.

‍

FAQ

‍

Can I have normal LDL but high ApoB?

‍Yes. This is common in people with metabolic syndrome or high triglycerides. When LDL particles are small and dense, the particle count can be high while cholesterol mass appears normal. ApoB catches this where LDL misses it.

‍

Does hsCRP go up during illness or after exercise?

‍Yes. Both acute infection and intense exercise temporarily spike hsCRP. For cardiovascular risk assessment, hsCRP should be measured when you are healthy and have not had intense exercise in the prior 48 hours. Repeat testing confirms whether elevation is chronic or transient.

‍

Is Lp(a) related to ApoB? Every Lp(a) particle contains one ApoB molecule, so elevated Lp(a) contributes to total ApoB. Lp(a) is largely genetically determined and doesn't respond to most lifestyle interventions, which is why it needs to be measured separately.

‍

Can diet alone normalize ApoB? For many people with mildly elevated ApoB driven by metabolic factors, yes. For those with genetic hypercholesterolaemia or very high baseline levels, medication is usually required alongside dietary changes.

‍

Summary

‍

ApoB and hsCRP are two of the most actionable cardiovascular markers available. ApoB tells you how many atherogenic particles are circulating. hsCRP tells you how inflamed your vascular environment is. Both respond to the same core interventions: reducing visceral fat, improving insulin sensitivity, eating less ultra-processed food, exercising regularly, and sleeping well.

‍

Melatonin has a modest, likely indirect role in reducing hsCRP for people with poor sleep. It is one input among many, not a primary strategy.

‍

The most useful thing you can do is measure both markers, establish your baseline, and track how they respond to the changes you make.

‍

Take Control of Your Health Today

What Raises and Lowers ApoB and hsCRP: A Practical Guide